Osteoarthritis (OA)
Complete Guide to Symptoms, Causes & Treatment Solutions

A deeper understanding of the condition and how to manage it effectively with ENDSAV's role in joint health support

Overview

Osteoarthritis (OA) is the most common type of joint disease worldwide and is considered the leading cause of mobility disability in older adults. The medical view of osteoarthritis is no longer limited to "wear and tear due to aging," but is now seen as a disease affecting the entire joint, including cartilage, bones, ligaments, and lining tissues.

What is Osteoarthritis? How Does It Occur?

Osteoarthritis occurs when the cartilage (the smooth, elastic tissue covering the ends of bones) gradually wears away. This cartilage acts as a cushion to absorb shock and facilitate movement without friction.

As cartilage wears down, bones begin to rub against each other, leading to changes in the bones themselves, deterioration of connective tissues that bind muscles to bones and stabilize the joint, and inflammation may occur in the joint lining.

Osteoarthritis Symptoms

Symptoms usually develop slowly and worsen over time:

Pain

The joint is affected during or after movement, and may increase with physical activity.

Stiffness

Particularly noticeable upon waking from sleep or after periods of inactivity such as prolonged sitting.

Loss of Flexibility

Inability to move the joint through its full range of motion.

Crepitus (Sounds)

A grating sensation or hearing a crackling sound when using the joint.

Swelling

Resulting from inflammation of the soft tissues around the joint.

Bone Spurs

Small pieces of bone that may form around the affected joint and feel like hard lumps.

Mayo Clinic – Osteoarthritis

Risk Factors

Why do some people develop osteoarthritis while others don't? There are factors that increase the likelihood of developing the condition:

  1. Advancing Age: The risk of developing OA increases with age due to natural cartilage wear.
  2. Sex: Women are more susceptible, especially after age 50, with hormonal changes believed to play a role.
  3. Obesity: Excess weight puts enormous pressure on weight-bearing joints (knees and hips), and fat tissue secretes proteins that may cause inflammation in and around joints.
  4. Joint Injuries: Previous injuries (during sports or accidents) increase the risk of developing OA in the future, even if they healed completely.
  5. Repetitive Stress: Jobs or sports that require repetitive stress on a specific joint increase the risk of wear.
  6. Genetic Factors: Some people have a hereditary predisposition to developing the condition.
NHS UK – Osteoarthritis

Diagnosis and Treatment

Diagnosis is made through clinical examination (checking for swelling, redness, and flexibility) and medical imaging (X-ray and sometimes MRI).

Treatment and Management Strategy

Osteoarthritis is a chronic disease that cannot be "completely cured" by returning the joint to its original state, but symptoms can be successfully managed to improve quality of life through:

  • Lifestyle Changes: Weight loss and muscle-strengthening exercises (under specialist supervision).
  • Physical Therapy: To improve flexibility, reduce stiffness, and strengthen muscles supporting the joint.
  • Medications: Pain relievers and anti-inflammatory drugs (NSAIDs) as needed and under medical supervision.
  • Joint-Supporting Dietary Supplements: To enhance cartilage health and reduce the need for pain relievers.

ENDSAV's Role in Joint Health Support

Modern osteoarthritis treatment relies on "multimodal therapy," meaning attacking the problem from multiple angles. ENDSAV offers a comprehensive "5-in-1" formula, designed based on the latest research to provide the necessary support for affected joints.

ENDSAV Medical Ingredients Analysis

Glucosamine Sulfate 660 mg

A natural compound found in cartilage. It helps maintain the health of remaining cartilage and may slow the wear process. Studies have shown its effectiveness in relieving pain and improving function in knee osteoarthritis patients when used for medium to long-term periods.

Chondroitin Sulfate 420 mg

Helps cartilage retain water, giving it elasticity and shock-absorbing ability. Often used with glucosamine to enhance the effect (Synergistic Effect).

Methylsulfonylmethane (MSM) 500 mg

A source of organic sulfur with powerful anti-inflammatory and antioxidant properties. It significantly helps reduce joint pain and stiffness, improving physical performance.

Collagen 60 mg

Collagen is the main structural protein in connective tissues. Taking it as a supplement may help the body regenerate damaged tissues and improve joint flexibility.

Hyaluronic Acid 10 mg

The main component of synovial fluid inside the joint, which acts as "lubricating oil" for the joint, reducing friction and facilitating smooth movement.

Why the Combined Formula? Instead of taking 3 or 4 different products, ENDSAV combines these elements in studied doses to work in synergy, making it easier for patients to adhere to treatment and reducing overall cost compared to buying each component separately.

NIH – Glucosamine and Chondroitin PubMed – Combined Supplements Study

Frequently Asked Questions

Can Osteoarthritis be completely cured?

Osteoarthritis is a chronic disease that cannot be completely cured, but symptoms can be successfully managed and quality of life significantly improved through appropriate treatment.

When do joint supplement results appear?

Supplements like glucosamine and chondroitin typically need 4 to 12 weeks of regular use to notice improvement.

Can ENDSAV be used with other medications?

It is recommended to consult a doctor before combining supplements with any other medications, especially blood thinners or diabetes medications.

Scientific References

  1. Mayo Clinic – Osteoarthritis: Symptoms and Causes https://www.mayoclinic.org/diseases-conditions/osteoarthritis/
  2. NHS UK – Osteoarthritis https://www.nhs.uk/conditions/osteoarthritis/
  3. NIH – Glucosamine and Chondroitin for Osteoarthritis https://www.nccih.nih.gov/health/glucosamine-and-chondroitin/
  4. PubMed – Combined Supplements Study (ID: 38948650) https://pubmed.ncbi.nlm.nih.gov/38948650/
Scroll to Top